Your session is about to expire
← Back to Search
Behavioral Exposure Therapy for Exercise Intolerance (BE-FIT Trial)
BE-FIT Trial Summary
This trial is testing a mechanism-informed behavioral intervention, BE-FIT, to target exercise anxiety in order to increase exercise outcomes. The intervention includes exposure to feared bodily sensations and exercise, prevention of safety behavior use, and use of a wrist-worn activity monitor for feedback and goal setting.
BE-FIT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBE-FIT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BE-FIT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am enrolled in a heart health rehab program.It is expected that the patient will not survive during the study.You haven't been very active, doing less than 90 minutes of moderate-to-vigorous exercise each day in the past three months.You have problems with your memory and thinking abilities, as shown by a test called the Montreal Cognitive Assessment (MoCA) where you scored 23 or lower.You experience high levels of anxiety when it comes to exercise (scoring 30 or higher on a specific questionnaire).I am 40 years old or older.
- Group 1: Behavioral Exposure For Introceptive Tolerance
- Group 2: Health Education Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential risks are associated with Behavioral Exposure For Introceptive Tolerance?
"Our team at Power assigned Behavioral Exposure For Introceptive Tolerance a score of 2 following our evaluation, as this is currently in the Phase 2 trial stage and has limited data supporting its safety but none proving efficacy."
What is the uppermost cap on participants of this research trial?
"Affirmative. Clinicaltrials.gov states that this experiment is currently looking for participants, which was first listed on May 3rd 2022 and recently edited on the 26th of May. The study requires 146 subjects to be recruited between 2 distinct sites."
Are there any openings for individuals to join this clinical trial?
"Correct. Per the information hosted on clinicaltrials.gov, this medical trial is recruiting participants with a start date of May 3rd 2022 and an update from May 26th 2022. 146 individuals need to be recruited across two sites for the study's success."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger